Ombajen, Helen M.
HRN: 23-11-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFUROXIME 500MG (TAB)
05/27/2023
06/03/2023
PO
500mg
BID X 7 Days
2nd Degree Perineal Laceration And Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes